David Liu, Ph.D. - Founder of Ensemble Therapeutics, Professor of Chemistry and Chemical Biology at Harvard University, Howard Hughes Medical Institute Investigator

David Armistead, Ph.D. - Executive in Residence at Oxford Bioscience Partners, former VP and Site Head of the Amgen Cambridge Research Center, co-founder of Kinetix Pharmaceuticals

Francis Barany, Ph.D. - Professor, Department of Microbiology and Program of Biochemistry and Structural Biology, Weil Cornell Medical College; Member of the joint Cornell/Sloan-Kettering Institute's Molecular Biology Program

Simon Campbell CBE, FMedSci, FRS – Formally senior vice president for Pfizer Worldwide Discovery and Medicinals R&D in Europe. Former President, Royal Society of Chemistry

Pat Confalone, Ph.D. - VP Research & Development, DuPont Crop Protection, previously SVP Bristol-Myers Squibb

Gerard Evan, Ph.D., FRS - Sir William Dunn Professor of Biochemistry and Head of Department of Biochemistry at the University of Cambridge, and Distinguished Professor of Cancer Research at UCSF Helen Diller Family Comprehensive Cancer Center

Mark Murcko, Ph.D. – formally VP, Chief Technology Officer and Chair of the Scientific Advisory Board of Vertex Pharmaceuticals

Craig A. Smith, Ph.D. - Co-founder, VLST Scientific Fellow and Chairman of the Scientific Advisory Board of VLST Corporation.

Michael E. Weinblatt, MD. - Co-director of Clinical Rheumatology at the Brigham and Women's Hospital and John R. Riedman Professor of Medicine at Harvard Medical School, both in Boston, Massachusetts

[ back to top ]